Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu

Immune Ablation and Hematopoietic Stem Cell Support in Patients With Systemic Lupus Erythematosus: A Phase II Study

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00271934
Recruitment Status : Completed
First Posted : January 4, 2006
Last Update Posted : April 11, 2012
Information provided by (Responsible Party):
Richard Burt, MD, Northwestern University